Physician Profile
John P. Schwerkoske, MD
Unclaimed ProfileAbout Dr. Schwerkoske
John P. Schwerkoske, MD practices hematology & oncology in Encinitas, CA. John is a 2012 graduate of Creighton University School of Medicine. Medicare claims data shows John provided 238 services to 102 patients. The services billed most often include administration of chemotherapy into vein, 1 hour or less, established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, and established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
Education & Training
Specialty
Credentials & Licensing
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (760) 452-3340
- Email not available
Practice Locations
326 SANTA FE DR STE 105
Encinitas, CA 92024
28078 Baxter Rd Ste 140
Murrieta, CA 92563
959 LANE AVE STE 100 BLDG B
Chula Vista, CA 91914
9850 Genesee Ave Ste 560
La Jolla, CA 92037
16918 Dove Canyon Rd Ste 103
San Diego, CA 92127
838 Nordahl Rd Ste 300
San Marcos, CA 92069
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
- Cancer That Has Spread
Blood & Lymph Disorders
- Enlarged spleen
- Swollen Lymph Nodes
Blood Cancers
- Multiple Myeloma
- Myelodysplastic Syndrome
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
- Bone tumors
- Soft-tissue sarcoma
Digestive Cancers
- Esophageal cancer
- Liver cancer
- Pancreatic cancer
- Stomach cancer
Endocrine Cancers
- Thyroid cancer
Endocrine tumors
- Neuroendocrine Tumors
Gastrointestinal cancer
- Anal cancer
- Appendix cancer
- Bile duct cancer
- Gallbladder cancer
General oncology
- Cancer of unknown primary
Genetic Blood Disorders
- Sickle cell disease
- Thalassemia
Gynecologic cancer
- Vulvar cancer
Gynecologic Cancers
- Cervical cancer
- Endometrial cancer
- Ovarian cancer
Head & Neck Cancers
- Oral cancer
Head and neck cancer
- Laryngeal cancer
- Oral cavity cancer
Neurologic Cancers
- Brain tumor
Oncologic emergencies
- High calcium from cancer
Ophthalmologic oncology
- Melanoma of the eye
Skin cancer
- Skin cancer
Skin Cancers
- Melanoma
Urologic Cancers
- Bladder cancer
- Kidney cancer
- Testicular cancer
Procedures & services
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Biopsies & Diagnostics
- Bone Marrow Biopsy
- Lumbar puncture
- Lymph Node Biopsy
Blood disorder care
- Blood Exchange Transfusion
- Photopheresis
Cancer Therapies
- Hormone Therapy For Cancer
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
- CAR-T Therapy
- Stem Cell Transplant
Consultations
- Cancer Survivorship Care Plan
- Clinical Trial Screening
- Second Opinion For Cancer
Diagnostic testing
- Circulating tumor cell test
Hematology Treatments
- Blood Clot Management
- Plasmapheresis
- PRP Injection
- Therapeutic Blood Draw
Imaging
- PET Scan
Infusions
- Clotting Factor Replacement
- Iron Infusion
- IV fluids
- IVIG Infusion
Interventional oncology
- Radiofrequency ablation
- TACE Chemoembolization
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
- Cancer Genetic Testing
- Cancer Tumor Profiling
- Liquid Biopsy
Vascular access care
- Chemo port check
- Chemo Port Flush And Maintenance
- PICC line dressing change
Procedures Most Often Billed to Medicare
238 services · 102 patients · 4 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
94 | Less often than most peers in Hematology & Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
19 | Less often than most peers in Hematology & Oncology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
77 | Less often than most peers in Hematology & Oncology |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Office visit | 99213 |
48 | Less often than most peers in Hematology & Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Other cancer specialists in Encinitas 5
Same specialty, same city.
Trained at Creighton University School of Medicine 8
Other providers in the same specialty who trained at the same institution.
More connections — 16 related providers in 2 groups
Class of 2012 at Creighton University School of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Administration of chemotherapy into vein, 1 hour or less 8
Providers in CA who bill this service to Medicare most often.
Common questions
What does Dr. Schwerkoske specialize in?
Dr. Schwerkoske is a cancer specialist in Encinitas, CA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Where is Dr. Schwerkoske located?
Dr. Schwerkoske is listed at 326 Santa Fe Dr Ste 105, Encinitas, CA 92024. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is Dr. Schwerkoske's phone number?
The number on file is (760) 452-3340. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
What is the NPI for Dr. Schwerkoske?
Dr. Schwerkoske's National Provider Identifier is 1912260829. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Dr. Schwerkoske go to medical school?
Dr. Schwerkoske attended Creighton University School of Medicine, graduating in 2012. This comes from the CMS National Downloadable File.
CMS public data
How much experience does Dr. Schwerkoske have?
Dr. Schwerkoske has 14 years experience. Calculated from a graduation year of 2012, reported in the CMS National Downloadable File.
CMS public data
What does Dr. Schwerkoske do most often?
According to Medicare billing data, Dr. Schwerkoske provides treatments such as administration of chemotherapy into vein, 1 hour or less and injection of drug or substance under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Is Dr. Schwerkoske's profile verified?
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Schwerkoske. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.